Hemophagocytic syndrome associated with retinoic acid syndrome in acute promyelocytic leukemia

Am J Hematol. 2004 Jun;76(2):172-5. doi: 10.1002/ajh.20071.

Abstract

A 56-year-old woman with an acute promyelocytic leukemia (APL) developed a severe all-trans-retinoic (ATRA) syndrome on day 17 of treatment. Shortly after, she presented a picture of pancytopenia, hepatosplenomegaly, increased triglycerides, ferritin, and liver enzymes. A bone marrow biopsy showed abundant macrophages and no evidence of leukemia. Tests for secondary hemophagocytic syndrome (HPS) were negative. A diagnosis of HPS was made. Treatment with dexamethasone and high-dose immunoglobulins was unsuccessful. Consolidation chemotherapy with idarubicin and ATRA rapidly reversed the HPS. The HPS in this patient could be related to the release of macrophage-stimulating cytokines by APL cells during ATRA syndrome.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / adverse effects
  • Female
  • Histiocytosis / chemically induced*
  • Humans
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Middle Aged
  • Syndrome
  • Treatment Outcome
  • Tretinoin / adverse effects*

Substances

  • Antineoplastic Agents
  • Tretinoin